Did you know that the U.S. NASH Action Plan is the first and only national action plan created to address the growing epidemic of NASH? In 2021, GLI NASH Council partners...
As the world continues to gain a better understanding of COVID-19 and ever present and new variants, Global Liver Institute wants to ensure that we are here to continue to guide, educate, and...
(Washington, D.C., May 3, 2022) – Global Liver Institute (GLI), a premier patient-led liver health nonprofit operating globally, is deeply concerned by the draft opinion published...
(Washington, D.C., April 29, 2022) – As leaders in the liver cancer community, Global Liver Institute and their Liver Cancers team expresses our gratitude and recognizes Dr. Ned Sharpless and...
Welcome to the very first edition of Pediatric & Rare Liver Diseases News! As we expand our offerings for and about this community, Global Liver Institute is also committed to keeping...
Today, April 6, the members of the Liver Action Network (LAN) pledge our collective support for Living Donor Day to honor the donors, recipients, families and caregivers, and clinical teams that...
Transforming Global Consciousness of Liver Health through Education and Advocacy (Washington, D.C., March 30, 2022) – Global Liver Institute (GLI), a patient-led liver health nonprofit...
New Season, New Format: Striving to meet the needs of the expanding liver health- interested community for timely information on must-know events and news specific to our Council communities...
Interested in learning more? Check out what GLI’s President and CEO Donna Cryer, JD has to say on Season 3, Episode 12 of Surfing the NASH Tsunami here. Nonalcoholic steatohepatitis (NASH) has a...
Global Liver Institute Launches Final Nonalcoholic Steatohepatitis (NASH) Externally-Led Patient-Focused Drug Development Meeting Outcome Report (Washington, DC, Wednesday, March 9,...
Recent News
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. Join Global Liver Institute to Push Congress to Advance Priority Bills and Support Agency Efforts.In the post-election...
New App Helps Predict Pediatric Transplant Need Upcoming Pediatric and Rare Liver Diseases Council Semi-Annual Meeting Our upcoming council meeting is scheduled for May 8, 2024. We're thrilled to welcome Alex Betourne, PhD, PharmD, the Scientific...
Providing Access to Rezdiffra for NASH and the Therapies to Come | AMCP 2024 At the Academy of Managed Care Pharmacy meeting on April 16, experts discussed the emerging landscape of NASH treatments, focusing on the recent approval of Madrigal’s Rezdiffra. Donna...
Global Liver Institute Thanks Senator Bill Cassidy for His Leadership in Fatty Liver Disease ResearchU.S. Agency for Healthcare Research and Quality to Assess True Prevalence and Impact of NAFLD/MASLD(Washington, D.C., May 1, 2024) – GLI applauds the announcement of a...
We extend our deepest gratitude to Dr. Jennifer Guy, Dr. Anjana Pillai, Dr. Christopher Rose, Dr. Elliot Tapper, patient advocate Bruce Dimming, and our sponsors. In case you missed it, our webinar ‘Liver Cancer Care: Management of Hepatic Encephalopathy, Ascites, and...
